New biomarkers identified to predict response to vedolizumab in patients with Crohn's disease Feb. 18, 2022
Serum PRO-C6 monitors and predicts infliximab response in patients with Crohn's disease Feb. 14, 2022
CK-BB predicts never awakening in patients treated with hypothermia after cardiac arrest Feb. 11, 2022